nurs 432 Final Exam questions with accurate answers
Abruptio Placentae Ans✓✓✓ premature separation of the placenta from
the uterine wall
S/SX: Vaginal bleeding, abdominal pain, uterine tenderness and
contraction
Abruptio Placentae: Active Management Ans✓✓✓ •Immediate birth if
term gestation, moderate to severe bleeding, or mom or fetus in jeopardy
•Monitor maternal VS for signs of declining hemodynamic status
(Increasing HR and decreasing BP)
•Indwelling catheter to monitor urinary output
Abruptio Placentae: Diagnosis Ans✓✓✓ U/S
-Do not perform pelvic exam
Abruptio Placentae: Expectant Management Ans✓✓✓ •If between 20-
36 weeks gestation and mom and baby are stable, expectant management
can be implemented
•Closely monitor mom
•Fetal: Assess for appropriate growth, fetal well being (NST and BPP),
and administer corticosteroids
Abruptio Placentae: Maternal and Fetal Outcome Ans✓✓✓ •Maternal:
hemorrhage, hypovolemic shock, hypofibrinogenemia,
thrombocytopenia, renal failure, pituitary necrosis
,•Fetal: IUGR, oligohydramnios, preterm birth, hypoxemia, and stillbirth
Alleles Ans✓✓✓ different versions of a gene
ALONE Ans✓✓✓ Amniocentesis
L/S Ratio
Oxytocin Test
NST
Estriol Level
Alpha-fetoprotein (AFP) Ans✓✓✓ •Maternal serum levels screened for
neural tube defects (NTDs)
•80% to 85% of open NTDs and abdominal wall defects can be detected
early
•Recommended for all pregnant women
Reliable any time between 15-20 weeks of gestation
amniocentesis Ans✓✓✓ needle puncture of the amniotic sac to
withdraw amniotic fluid for analysis to r/o genetic disorder or congenital
anomalies
•Collects sample of amniotic fluid
•Needs consent bc invasive
•US guided mandatory to prevent complications
,Amniotic fluid volume Ans✓✓✓ Deepest vertical pocket >2cm
Anemia Ans✓✓✓ •Iron deficiency anemia
•Folic acid deficiency
•Sickle cell
•Thalassemia
Antepartum Management Ans✓✓✓ •HbA1c
•Diet
•Exercise
•Insulin therapy
•Blood glucose levels
•Urine testing
•Complications requiring hospitalization
•Fetal surveillance
•Birth date and mode of birth
Assessment of PTL Ans✓✓✓ •Assess fetal well being
•Monitor for baseline uterine activity
•Cervical exam
•Sterile speculum exam for ROM
•Screen for UTI and other infections
•US
, Biophysical Profile (BPP) Ans✓✓✓ Surveillance test to determine fetal
well being
Involves US and NST
Biophysical risks Ans✓✓✓ Factors that originate within the mother or
fetus and affect the development or functioning of either one or both
body movement Ans✓✓✓ At least 3 trunk/limb movements over 30
minutes
BPP score less than 6 Ans✓✓✓ Consider delivery if + testing for fetal
lung maturation or oligohydramnios; if preterm repeat test or extend
timing
Causes of Antepartum Hemorrhagic Disorders in 1st Trimester
Ans✓✓✓ Miscarriage (spontaneous abortions), cervical insufficiencies,
ectopic pregnancy, and hydatidiform mole (molar pregnancy)
Causes of Antepartum Hemorrhagic Disorders in 3rd Trimester
Ans✓✓✓ Placenta previa and abruptio placentae
Causes of spontaneous abortion Ans✓✓✓ Aging gamete after ovulation
Endocrine imbalance
Hypothyroidism
Abruptio Placentae Ans✓✓✓ premature separation of the placenta from
the uterine wall
S/SX: Vaginal bleeding, abdominal pain, uterine tenderness and
contraction
Abruptio Placentae: Active Management Ans✓✓✓ •Immediate birth if
term gestation, moderate to severe bleeding, or mom or fetus in jeopardy
•Monitor maternal VS for signs of declining hemodynamic status
(Increasing HR and decreasing BP)
•Indwelling catheter to monitor urinary output
Abruptio Placentae: Diagnosis Ans✓✓✓ U/S
-Do not perform pelvic exam
Abruptio Placentae: Expectant Management Ans✓✓✓ •If between 20-
36 weeks gestation and mom and baby are stable, expectant management
can be implemented
•Closely monitor mom
•Fetal: Assess for appropriate growth, fetal well being (NST and BPP),
and administer corticosteroids
Abruptio Placentae: Maternal and Fetal Outcome Ans✓✓✓ •Maternal:
hemorrhage, hypovolemic shock, hypofibrinogenemia,
thrombocytopenia, renal failure, pituitary necrosis
,•Fetal: IUGR, oligohydramnios, preterm birth, hypoxemia, and stillbirth
Alleles Ans✓✓✓ different versions of a gene
ALONE Ans✓✓✓ Amniocentesis
L/S Ratio
Oxytocin Test
NST
Estriol Level
Alpha-fetoprotein (AFP) Ans✓✓✓ •Maternal serum levels screened for
neural tube defects (NTDs)
•80% to 85% of open NTDs and abdominal wall defects can be detected
early
•Recommended for all pregnant women
Reliable any time between 15-20 weeks of gestation
amniocentesis Ans✓✓✓ needle puncture of the amniotic sac to
withdraw amniotic fluid for analysis to r/o genetic disorder or congenital
anomalies
•Collects sample of amniotic fluid
•Needs consent bc invasive
•US guided mandatory to prevent complications
,Amniotic fluid volume Ans✓✓✓ Deepest vertical pocket >2cm
Anemia Ans✓✓✓ •Iron deficiency anemia
•Folic acid deficiency
•Sickle cell
•Thalassemia
Antepartum Management Ans✓✓✓ •HbA1c
•Diet
•Exercise
•Insulin therapy
•Blood glucose levels
•Urine testing
•Complications requiring hospitalization
•Fetal surveillance
•Birth date and mode of birth
Assessment of PTL Ans✓✓✓ •Assess fetal well being
•Monitor for baseline uterine activity
•Cervical exam
•Sterile speculum exam for ROM
•Screen for UTI and other infections
•US
, Biophysical Profile (BPP) Ans✓✓✓ Surveillance test to determine fetal
well being
Involves US and NST
Biophysical risks Ans✓✓✓ Factors that originate within the mother or
fetus and affect the development or functioning of either one or both
body movement Ans✓✓✓ At least 3 trunk/limb movements over 30
minutes
BPP score less than 6 Ans✓✓✓ Consider delivery if + testing for fetal
lung maturation or oligohydramnios; if preterm repeat test or extend
timing
Causes of Antepartum Hemorrhagic Disorders in 1st Trimester
Ans✓✓✓ Miscarriage (spontaneous abortions), cervical insufficiencies,
ectopic pregnancy, and hydatidiform mole (molar pregnancy)
Causes of Antepartum Hemorrhagic Disorders in 3rd Trimester
Ans✓✓✓ Placenta previa and abruptio placentae
Causes of spontaneous abortion Ans✓✓✓ Aging gamete after ovulation
Endocrine imbalance
Hypothyroidism
